Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 24.96

+1.1%

10:18 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (1585)	8/26/1999 9:34:00 AM
From: Henry Niman	of 1722

Latest scrips indicate that LLY's Avandia continues to grab market share from WLA's Rezulin. Actos just getting started. NSABP is starting to enroll patients for TZD treatment of ulcerative colitis and they will be using Avandia. Details in Bear Stearns Bottle report abstract linked to Selected Pharma stories at netcognizance.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next